Ultrasensitive Detection of Neurodegenerative Biomarkers in Blood: Powering a New Era in Alzheimer’s Disease Research
AD is a growing public health challenge, with the number of affected Americans projected to reach 8.5 million by 2030 and 13.8 million by 2060.1 Accessible and accurate tools for early detection and longitudinal studies have the potential to advance basic research and improve disease management. Traditional AD detection requires cerebrospinal fluid samples or expensive […]